Miles W. Mchugh's most recent trade in Horizon Therapeutics Plc was a trade of 18,289 Ordinary Shares done . Disclosure was reported to the exchange on Jan. 4, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 18,289 | 54,810 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 8,992 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.84 per share. | 04 Jan 2022 | 8,175 | 46,635 (0%) | 0% | 101.8 | 832,542 | Ordinary Shares |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 7,617 | 7,617 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 5,805 | 5,806 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 3,492 | 6,986 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Sale of securities on an exchange or to another person at price $ 106.62 per share. | 01 Dec 2021 | 79,484 | 36,521 (0%) | 0% | 106.6 | 8,474,584 | Ordinary Shares |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 79,484 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 01 Dec 2021 | 79,484 | 116,005 (0%) | 0% | 22.1 | 1,759,776 | Ordinary Shares |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 3,334 | 37,998 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 3,334 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Miles W. Mchugh | Sr VP & Princ. Acctg Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.95 per share. | 10 Jun 2021 | 1,477 | 36,521 (0%) | 0% | 93.9 | 138,764 | Ordinary Shares |